Ipsen (FRA:I7G0) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:I7G0 Ipsen SA FRA:I7G0
97 GF Score
Price €38.80
GF Value €34.23
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ipsen FFO per Share?

FFO per Share only applies to REITs.

FRA:I7G0
97GF Score
Ipsen SA FRA:I7G0
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ipsen (FRA:I7G0) Overvalued in 2026?

Based on GuruFocus' analysis, Ipsen stock appears to be overvalued. The current stock price of €38.80 is trading 13.4% above its estimated GF Value™ of €34.23. GuruFocus considers Ipsen to be Fairly Valued.

Key valuation signals for FRA:I7G0:

  • FFO per Share:
  • GF Value™: €34.23 vs. price of €38.80 (13.4% above fair value)
  • GF Score™: 97/100 with 6 warning signs

No single metric tells the full story. See the FRA:I7G0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ipsen Business Description

Address 70 rue Balard, Paris, FRA, 75015
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 20 drugs in 115 countries.
97GF Score

Get the complete analysis for FRA:I7G0

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€38.80
Price
€34.23
GF Value